Prince of Wales Hospital is a regional acute government hospital located in Sha Tin, New Territories in Hong Kong. It is also a teaching hospital of the Faculty of Medicine of the Chinese University of Hong Kong.

There are 1,807 beds in Prince of Wales Hospital.

During the past decade, Prince of Wales Hospital conducted 317 clinical trials. In the 10-year time frame, 317 clinical trials started and 67 clinical trials were completed, i.e. on average, 21.1% percent of trials that started reached the finish line to date. In the past 5 years, 182 clinical trials started and 46 clinical trials were completed. i.e. 25.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prince of Wales Hospital" #1 sponsor was "Chinese University of Hong Kong" with 246 trials, followed by "Abbott Medical Devices" with 16 trials sponsored, "Boehringer Ingelheim" with 15 trials sponsored, "Pfizer" with 14 trials sponsored and "Boston Scientific Corporation" with 14 trials sponsored. Other sponsors include 155 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prince of Wales Hospital" #1 collaborator was "Prince of Wales Hospital, Shatin, Hong Kong" with 12 trials as a collaborator, "The University of Hong Kong" with 7 trials as a collaborator, "Chinese University of Hong Kong" with 6 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator and "Queen Elizabeth Hospital, Hong Kong" with 4 trials as a collaborator. Other collaborators include 146 different institutions and companies that were collaborators in the rest 131 trials.

According to Clinical.Site data, the most researched conditions in "Prince of Wales Hospital" are "Prostate Cancer" (14 trials), "Stroke" (11 trials), "Colorectal Cancer" (10 trials), "Obstructive Sleep Apnea" (9 trials) and "Chronic Hepatitis B" (8 trials). Many other conditions were trialed in "Prince of Wales Hospital" in a lesser frequency.

Most popular intervention types in "Prince of Wales Hospital" are "Drug" (183 trials), "Device" (90 trials), "Procedure" (54 trials), "Other" (52 trials) and "Biological" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "No intervention" (10 trials), "Cisplatin" (7 trials), "Pembrolizumab" (5 trials) and "TAF" (4 trials). Other intervention names were less common.

The vast majority of trials in "Prince of Wales Hospital" are 422 trials for "All" genders, 29 trials for "Male" genders and 13 trials for "Female" genders.

Currently, there are 179 active trials in "Prince of Wales Hospital". 9 are not yet recruiting, 121 are recruiting, 46 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 192 completed trials in Prince of Wales Hospital, 3 suspended trials, and 37 terminated clinical trials to date.

Out of the total trials that were conducted in Prince of Wales Hospital, 23 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 35 trials, and there were also 142 trials that are defined as “Not Applicable".

Prince of Wales Hospital has several departments that took part in Clinical trials: "Endoscopy Centre, Prince of Wales Hospital" - 28 trials